Home/Filings/4/0000897069-25-001547
4//SEC Filing

SKIBSTED RUSSELL 4

Accession 0000897069-25-001547

CIK 0001533743other

Filed

Oct 2, 8:00 PM ET

Accepted

Oct 3, 4:27 PM ET

Size

7.5 KB

Accession

0000897069-25-001547

Insider Transaction Report

Form 4
Period: 2025-10-01
SKIBSTED RUSSELL
Chief Financial Officer
Transactions
  • Award

    Stock Options (Right to Buy)

    2025-10-01+324,000324,000 total
    Exercise: $0.20Common Stock (324,000 underlying)
  • Award

    Restricted Stock Units

    2025-10-01+108,000108,000 total
    Exercise: $0.00Common Stock (108,000 underlying)
Footnotes (2)
  • [F1]Each Restricted Stock Unit represents a contingent right to receive one share of the Issuer's common stock, following its vesting on of one-third on October 1, 2026, and one-thirty-sixth each month thereafter until fully vested on October 1, 2028.
  • [F2]Stock options vest one-third on the first anniversary date of the grant, with the remaining options vesting ratably over the subsequent two years.

Documents

1 file

Issuer

Processa Pharmaceuticals, Inc.

CIK 0001533743

Entity typeother

Related Parties

1
  • filerCIK 0001308105

Filing Metadata

Form type
4
Filed
Oct 2, 8:00 PM ET
Accepted
Oct 3, 4:27 PM ET
Size
7.5 KB